Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief:

Khurshid Zaman  
Bentham Science Publishers
USA

Back



Meet Our Editorial Board Member free to download

Volume:12   Issue:4
Pp: 281-282
Irena Kostova
DOI: 10.2174/157489281204171120102640



From a Better Understanding of the Mechanisms of Action of Histone Deacetylases Inhibitors to the Progress of the Treatment of Malignant Lymphomas and Plasma Cell Myeloma open access plus

Volume:12   Issue:4
Pp: 283-295
Romeo G. Mihaila*
DOI: 10.2174/1574892812666170920110054



Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs

Volume:12   Issue:4
Pp: 296-322
Qing-Yuan Lan, Yan-Le Zhi, Hao Heng, Jie-Yi Tian, Xiao-Xing Guo, Hai-Chun Liu, Ya-Dong Chen, Tao Lu* and Shuai Lu*
DOI: 10.2174/1574892812666170727154643



Synergistic Effect of Epidermal Growth Factor Receptor Inhibitors and Ionization Radiation in Cancer Treatment

Volume:12   Issue:4
Pp: 323-339
Zahra Shaghaghi and Seyed Jalal Hosseinimehr*
DOI: 10.2174/1574892812666170829150057



BET Inhibitors as Anticancer Agents: A Patent Review

Volume:12   Issue:4
Pp: 340-364
Imran Ali, Gildon Choi* and Kwangho Lee*
DOI: 10.2174/1574892812666170808121228



3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors

Volume:12   Issue:4
Pp: 365-383
Tooba Abdizadeh, Razieh Ghodsi and Farzin Hadizadeh*
DOI: 10.2174/1574892812666170508125927



Patent Selections promotion: free to download

Volume:12   Issue:4
Pp: 401-404

DOI: 10.2174/157489281204171120115232



Acknowledgements to Contributors free to download

Volume:12   Issue:4
Pp: 405-405

DOI: 10.2174/157489281204171120115407



Acknowledgements to Reviewers free to download

Volume:12   Issue:4
Pp: 406-406

DOI: 10.2174/157489281204171120115554